Month: January 2022

Figure 1Madison Project MAG Survey Map and Previously Reported Sampling DataFigure 2Madison Project Surface Sampling to DateVANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — American Pacific Mining Corp (CSE: USGD / OTCQB: USGDF / FWB: 1QC) (“American Pacific” or “the Company”) is pleased to report results of a recently completed Unmanned Aerial Vehicle (“UAV”) Drone magnetic survey over the Madison Property conducted in July by MWH Geo-Surveys of Reno, Nevada. A total of 344 line-kilometers (km) of UAV magnetic data was compiled at a line spacing of 25 metres (m) and 50m over an area of approximately 11.34 km². Prior to the magnetic survey, a UAV orthophoto survey was used to create a digital elevation model to guide the subsequent magnetic survey. Drone surveys are recent innovations...

– CX-904 is CytomX’s first T-cell-engaging bispecific antibody and the sixth Probody® therapeutic candidate to enter the clinic – SOUTH SAN FRANCISCO, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for CX-904, an EGFRxCD3 T-cell-engaging bispecific antibody being co-developed by CytomX and Amgen. “The impressive innovation of CX-904’s design and its advancement into the clinical setting underscores our commitment to destroying cancer differently. The CX-904 IND also marks the sixth therapeutic candidate and the third treatment modality overall to enter the clinic from our versatile and tunable...

ATLANTA, Jan. 19, 2022 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release its financial results for the fiscal first quarter ended December 31, 2021 on January 31, 2022 after the market closes. DLH will then host a conference call for the investment community at 10:00 a.m. Eastern Time on February 1, 2022 during which members of senior management will make a brief presentation focused on the financial results and operating trends. A question-and-answer session will follow.  Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call. A digital...

World’s first FDA-cleared portable MRI expands leading neurosurgery suite’s tech capabilities for novel diagnostic and therapeutic approaches GUILFORD, Conn. and MINNEAPOLIS, Jan. 19, 2022 (GLOBE NEWSWIRE) — Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)™ device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview University of Minnesota Medical Center. The hospital is the first in the state of Minnesota, and one of the first in the country, to offer this technology to its patients. “Forward thinking academic institutions like University of Minnesota are leading the charge adopting...

Leading Oral Care Company Has Teamed with Peloton Star Tunde Oyeneyin to Promote the Power of a Bright and Healthy SmileSmileDirectClubFast-Dissolving Whitening StripsSmileDirectClubTunde OyeneyinNASHVILLE, Tenn., Jan. 19, 2022 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the expansion of its award-winning whitening product line with its new Fast-Dissolving Whitening Strips. The new convenient and easy to use Fast-Dissolving Whitening Strips are the ideal whitening treatment for those who want results fast, without the mess of traditional whitening strips. With a short wear time – just once a day for 15 minutes – the Fast-Dissolving Whitening Strips are perfect for those who...

GREENSBORO, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, will host a conference call to review fiscal 2022 third quarter financial results on Wednesday, February 2, 2022, at 5:00 p.m. (ET). The conference call will be webcast live on the Company’s website at the following URL: http://www.qorvo.com (under “Investors”). A telephone playback of the conference call will be available approximately two hours after the call’s completion and can be accessed by dialing 719-457-0820 and using the passcode 5371000. The playback will be available through the close of business February 9, 2022. Qorvo will distribute fiscal 2022 third quarter financial results at approximately 4:00 p.m. (ET) on Wednesday, February 2, 2022. About QorvoQorvo (Nasdaq: QRVO)...

Highlights:Seven subjects in cohort two intravenously dosed with RECCE® 327 (R327) at 150mg met all endpoints – indicating R327 is safe and well tolerated Independent Safety Committee clears third study cohort to be dosed at 500mg – a tenfold increase from cohort one (50mg) and a threefold increase from cohort two (150mg) in dose per approved protocol Third cohort dosing of R327 (500mg) on track to begin this weekSYDNEY, Australia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing new classes of synthetic anti-infectives, is pleased to report further positive data from its Phase I intravenous (IV) clinical trial of RECCE® 327 (R327), demonstrating safety and tolerability among seven healthy male subjects in cohort two. Based upon these clinical data...

A Novel Platform to Create Multi-Functional Immunotherapeutics for Cancer Will Feature TOBI™ Discovery Platform and Lead Product Candidate, HCW9218 MIRAMAR, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced that Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, will speak at the Cambridge Healthtech Institute’s 24th Annual PepTalk Conference to be held on January 17-19, 2022 (https://www.chi-peptalk.com/protein-expression-production). The conference is taking place virtually and in person at the Hilton San Diego Bayfront in San Diego, California. Dr. Wong’s...

BURBANK, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of the Company’s product, Escozine, as a COVID-19 treatment. The product, which is registered as an alternative oncological medicine in the DR, has shown to be effective against variations of the SARS-CoV-2 virus. After the recent meeting between Medolife CEO Dr. Mikaelian and DR Vice-President Raquel Peña de Antuña that concluded with interest from the government to register the product as a...

Vancouver, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — GSP Resource Corp. (TSX-V: GSPR) (FRA: 0YD) (the “Company” or “GSP”) provides shareholders with the following outlook for 2022 and review of 2021 activities. GSP’s core asset is an option to acquire a 100% interest in the past producing Alwin Copper Mine located in BC’s Highland Valley Copper Camp. Simon Dyakowski CEO of GSP commented: “GSP had a productive year in 2021. Despite logistical challenges driven by poor weather with the Summer wildfires and Autumn flooding, GSP was able to complete approximately 2,300 meters of diamond drilling (8 holes), bringing GSP’s total drilling at the Alwin Mine Project to approximately 4,300 meters (18 holes) over the previous two exploration seasons. Other milestones achieved at Alwin last year include obtaining an important 5-year...